← Archive
November 2, 2026Health & Welfare

The Daily Brief for Benefits Professionals

BenefitsWire

Health & Welfare Plans

November 2, 2026

— § —

13 items · ~3 min read

In this issue

Regulatory Action and Guidance (10)  ·  Litigation (2)  ·  General Benefits (1)

Regulatory Action and Guidance

10 items
Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure

⏱ Effective Jan 4

The Department of Labor issued a final rule requiring pharmacy benefit managers to disclose their compensation to fiduciaries of large, self-insured group health plans, enabling fiduciaries to assess contract reasonableness and potentially lower drug costs. MORE >>

Source: Department of Labor

The 120th Congress: What’s in Store for Retirement Policy?

“By: Tony Roda, Williams & Jensen PLLC With a late October deadline for this article, it became an obvious challenge to write about the next Congress without first knowing the outcome of the November 3 elections.” MORE >>

Source: NCPERS

Developing PBM Transparency Moves Forward: DOL Finalizes its Disclosure Rule

“Find Your Next Job ! Federal efforts to bring greater transparency to pharmacy benefit manager (“PBM”) compensation are advancing. On October 29, 2026, the Department of Labor (“DOL”) released its final PBM compensation disclosure rule for large, self-insured ERISA health plans (“Final Rule”).” MORE >>

Source: Sheppard Mullin

ERIC Health Care Policy Highlights: NSA IDRE Recertification Happening; State Menopause Laws Blog Post; and More

“Forgot Your Password? If you do not yet have an ERIC Online profile or user name and password, please create one using Create Profile Form. If you need assistance with your user name/password or profile, please contact ERIC at (202) 789-1400.” MORE >>

Source: ERIC

Peptides: HHS Announces Limited Enforcement Discretion for Compounding of Six Peptides

“On October 28, 2026, HHS issued the document, HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances(“limited enforcement discretion policy”). FDA’s future rulemaking may propose adding some or all of these substances to the bulks list. Key Circumstances to be Met for Limited Enforcement Discretion: This “limited enforcement discretion policy” states that the Secretary of HHS has determined that, if all specified circumstances are met, HHS does not intend to take enforcement action against covered compounders using these six peptide bulk drug substances.” MORE >>

Source: Foley & Lardner

Chair Walberg Praises DOL Rule to Expose Hidden PBM Fees, Lower Drug Costs

The Department of Labor's final rule mandates PBMs disclose hidden fees and compensation to employers, enhancing transparency in prescription drug costs and aiming to lower expenses for American families. MORE >>

Source: House Education & Workforce Committee

Court Blocks CMS’s Narrower Definition of Medical Frailty Under Medicaid Work Requirements

“On October 29, 2026, a federal district court in Massachusetts struck down part of CMS’s Medicaid community engagement rule, ruling that CMS exceeded its statutory authority by narrowing the definition of “medically frail” individuals who may qualify for an exemption from the new requirements. The court’s decision to set aside the challenged requirement applies nationwide, while its injunction against enforcement applies only to the 25 plaintiff states and the District of Columbia.” MORE >>

Source: Groom Law Group

Developing Final ‘Transparency In Coverage’ Rule Clears OMB

“The much-anticipated final rule updating requirements for insurers and group health plans to publish negotiated prices has cleared the White House Office of Management and Budget.” MORE >>

Source: insidehealthpolicy.com

Developing Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Payment, and ESRD Quality Incentive Program

CMS finalized updates to the End-Stage Renal Disease (ESRD) Prospective Payment System for 2027, including revisions to payment rates for acute kidney injury dialysis and the ESRD Quality Incentive Program. MORE >>

Source: Federal Register

New DOL rule requires PBMs to be more transparent on what they charge employers

“Last week, the Department of Labor’s Employee Benefits Security Administration released a rule requiring PBMs and their affiliated brokers and consultants to disclose the fees and compensation they receive, so employers can negotiate contracts and seek lower prescription drug costs for their customers. The agency projected the rule would lower prescription drug costs by up to $22 billion over 10 years. Additionally, the final rule provides important compliance-assistance information for all service providers to employer-sponsored group health plans, which are now required to report fees and compensation to group health plan fiduciaries in initial plan and semi-annual disclosures.” MORE >>

Source: ncpa.org

Litigation

2 items
Ninth Circuit Holds that California’s Captive-Audience Ban Violates the First Amendment

“In a unanimous opinion, a three-judge panel of the Ninth Circuit held that California’s ban on “captive-audience” meetings violates the First Amendment. The court explained that the ban regulates speech based on the speech’s content. As a content-based regulation, the ban triggered the strictest level of constitutional review—“strict scrutiny.” The ban could not pass that test.” MORE >>

Source: Littler

Sixth Circuit Affirms Denial of Prejudgment Interest and Attorney’s Fees Where the Policy Gave LINA Discretion to Require a Death Certificate as Proof of Loss

“66 Franklin Street, Suite 300 Oakland, CA 94607 Williamson v. Life Insurance Company of North America, No. 25-5790, 2026 WL 3153191 (6th Cir. Oct. 21, 2026) (Before: Kethledge, Chief Judge; Cole and Mathis, Circuit Judges).” MORE >>

Source: Roberts Disability Law

General Benefits

1 item
Key Considerations in Responding to a Corporate Criminal Healthcare Case

“06.30.2026 New York, NY Kevin Lowell will speak at the American Health Law Association (AHLA) Annual Meeting and In-House Counsel Program on June 30, 2026. Lowell will present, as a part of a panel, "Key Considerations in Responding to a Corporate Criminal Healthcare Case.” MORE >>

Source: Hall Benefits Law

Also of Note

BenefitsWire · A digest for ERISA attorneys, third-party administrators, actuaries, recordkeepers, and benefits consultants.
An informational digest, not legal advice.
BDK2, LLC, 2503D N Harrison St PMB 2091, Arlington, VA 22207-1640

Get this in your inbox every morning.

Subscribe free